Spotlight On... Vet drugmaker Chanelle Group putting €70M into Ireland plant; India close on new API import rules; Indonesia changes API plant ownership rule; and more...

Ireland-based Chanelle Group, a maker of veterinary generic drugs, has big plans for its manufacturing facility in Loughrea County in Galway. It will invest €70 million ($78 million) to double capacity and will add 175 jobs when it is complete, bringing the company's employment to more than 550 in West Ireland. Construction on the 30,000-square-foot expansion is slated to begin in March, the company said in an announcement. Michael Burke, founder and managing director of Chanelle Group, said the company will also be expanding into new markets, including the U.S. and Central and South America. Release

> India expects within the month to have a new policy that would reduce the amount of APIs it is importing, particularly from China. Story

> China is working to do a better job of overseeing manufacturing quality as one point in a multifaceted healthcare reform program. Report

> Indonesia is dropping its 85% limit for foreign companies investing in API producers in the country in an effort to attract more local production. Report

Suggested Articles

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.